4//SEC Filing
Emergent BioSolutions Inc. 4
Accession 0001367644-07-000093
$EBSCIK 0001367644operating
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:23 PM ET
Size
13.7 KB
Accession
0001367644-07-000093
Insider Transaction Report
Form 4
Keese Kyle
SVP, Mfg Ops
Transactions
- Exercise/Conversion
Common Stock
2007-06-26$2.74/sh+1,445$3,959→ 8,566 total - Sale
Common Stock
2007-06-26$9.36/sh−1,445$13,525→ 7,121 total - Sale
Common Stock
2007-06-27$9.58/sh−1,445$13,843→ 7,121 total - Exercise/Conversion
Employee Stock Option (right to buy)
2007-06-26−1,445→ 4,336 totalExercise: $2.74Exp: 2007-06-30→ Common Stock (1,445 underlying) - Exercise/Conversion
Common Stock
2007-06-27$2.74/sh+1,445$3,959→ 8,566 total - Exercise/Conversion
Employee Stock Option (right to buy)
2007-06-27−1,445→ 2,891 totalExercise: $2.74Exp: 2007-06-30→ Common Stock (1,445 underlying)
Footnotes (3)
- [F1]The option became fully vested on December 31, 2006 and will expire on June 30, 2007.
- [F2]Reflects the average sales price of shares sold by Merrill Lynch on such date in its administration of Rule 10b5-1 trading plans for Emergent BioSolutions Inc. common stock. These shares were sold at prices ranging from $9.21 to $9.45 per share.
- [F3]Reflects the average sales price of shares sold by Merrill Lynch on such date in its administration of Rule 10b5-1 trading plans for Emergent BioSolutions Inc. common stock. These shares were sold at prices ranging from $9.39 to $9.82 per share.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001367644
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:23 PM ET
- Size
- 13.7 KB